日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

TCM soup can help cut COVID-19 death rate of patients in half, study shows

By WANG XIAOYU | CHINA DAILY | Updated: 2021-05-10 09:21
Share
Share - WeChat
Pharmacists dispense medicines according to Qingfei Paidu Soup prescriptions at Anhui University of Chinese Medicine on Feb 21, 2020. [Photo/Xinhua]

Qingfei paidu soup, a widely used traditional Chinese medicine to treat COVID-19 infections, can help reduce the rate of death among hospitalized patients by half, a recent study has shown.

The study examines more than 8,900 COVID-19 cases that received treatment at 15 hospitals in Hubei province-the hardest-hit region during the epidemic-from January to May last year, with nearly 30 percent of them having taken qingfei paidu as part of their therapies.

Results suggest that the mortality rate for those undergoing the TCM treatment stands at 1.2 percent, while the rate for other patients is 4.8 percent.

The study, led by researchers from Fuwai Hospital of the Chinese Academy of Medical Sciences & Peking Union Medical College, concluded that the use of qingfei paidu is associated with a 50 percent reduction of mortality in hospitalized COVID-19 patients, without amplifying the risk of developing acute liver or kidney injuries.

It was first published on preprint website MedRxiv.org in late December. On March 31, it was released on Phytomedicine, a peer-reviewed journal.

Li Jing, head of the research team, said based on the national diagnosis and treatment guideline for COVID-19 diseases, qingfei paidu is the only prescription that is recommended for treating all patients ranging from mild to critical cases.

"The extensive delivery of TCM medication in hospitalized patients during the outbreak had created a sound base for our research because when appraising clinical effectiveness of a certain drug, it is crucial to start by collecting and analyzing from a large enough number of cases," she said.

Qingfei paidu is a concoction that includes dozens of TCM herbs and roots, including ephedra, licorice root and bitter almond. The initial version of the prescription is believed to have originated during the Eastern Han Dynasty (25-220).

Zhang Boli, president of the Tianjin University of Traditional Chinese Medicine, said during an earlier interview that preliminary studies show the therapy mainly works on lungs while offering protection for some other organs against the virus. It can also stem the virus's replication, Zhang said.

According to the National Administration of Traditional Chinese Medicine, previous studies have already attested to the herbal prescription's efficacy in preventing mild and moderate cases from worsening into severe infections, but evidence of its role in lowering the death rate was lacking.

"The study is by far the largest clinical research on qingfei paidu and its findings have provided potent evidence for proving its marked efficacy in saving the lives of COVID-19 patients," the administration said.

As of now, there is no approved specific treatment for COVID-19 patients. During the fight against the epidemic, 92 percent of confirmed patients had undergone TCM therapies, with the efficacy rate in Hubei reaching 90 percent, according to a white paper released in June.

Li said the new study is retrospective and based on real-world cases.

"If a randomized, double-blind, placebo-controlled clinical study can be conducted in the future, the TCM drug's clinical efficacy can be further verified, and its global application is expected to expand," she added.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 国产伦精品 | 欧美精品在线一区 | 九九99久久| 国产伦理久久精品久久久久 | 成人免费网站视频 | 瑟瑟网站免费网站入口 | 成人18视频在线 | 日韩精品区 | yy4138理论片在线大全 | 欧洲精品色 | a久久| 十八勿入| 韩国精品免费视频 | 久久视频一区 | 欧美国产二区 | 欧美久草| 欧美日韩大片在线观看 | 一级做a爰片久久毛片看看 欧美日韩精品国产一区二区 | 中文字幕精品一区二区三区精品 | 亚洲AV久久综合无码东京 | 嫩草影院网站 | 性色网站| 久久精品国产精品青草图片 | 一区二区三区免费在线观看 | 精品无人乱码一区二区三区 | 精品欧美在线观看 | 精品国产乱码久久久久久牛牛 | 日韩中文一区二区三区 | 福利网在线 | 曰批全过程40分钟免费视频多人 | 视频一区二区在线观看 | 色噜噜色噜噜天天拍一拍 | 精品国产中文字幕 | 日韩精品不卡 | 免费色网址 | 一区二区三区视频在线观看 | 精品九九 | 一级成人| 日日操免费视频 | 高清一区二区三区四区五区 | 国产在线精品区 |